臨床外科68巻6号

2013年06月発行

特集 胃癌腹膜転移治療の最前線

胃癌腹膜転移に対する腹腔内化学療法の理論と実際

著者： 伏田幸夫¹ 柄田智也¹ 木下淳¹ 尾山勝信¹ 藤村隆¹ 太田哲生¹

所属機関： ¹金沢大学消化器・乳腺・移植再生外科

ページ範囲：P.662 - P.667

文献概要

【ポイント】

◆腹腔内化学療法では感受性のある抗癌剤を高濃度で長時間，播種巣に接触させることが理想的であり，局所（腹膜）に炎症の生じにくい反復投与可能な薬剤が望ましい．

◆治療的腹腔内化学療法では他病巣に対する効果が少ないため，全身化学療法との併用が望ましい．

◆腹膜播種の評価は困難であるため，手術可能症例の選別には審査腹腔鏡は必須と考える．

参考文献

1）Rosen HR, Jatzko G, Repse S, et al：Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer：results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology. J Clin Oncol 16：2733-2738, 1998

2）Miyashiro I, Furukawa H, Sasako M, et al：Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin follpwed by oral fluorouracil（UFT）in serosa-positive gastric cancer versus curative resection alone：final results of the Japan Clinical Oncology Group trial JCOG9206-2. Gastric Cancer 14：212-218, 2011

3）Ohshima T, Yamada R, Hatri S, et al：Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer. Oncology Rep 16：361-366, 2006

4）Naitoh H, Kawaguchi A, Yamamoto H, et al：Mesurement of docetaxel concentration in blood and ascites after drop infusion into each vessel and intraperitoneal cavity of gastric cancer. Jpn J Chemother 31：2031-2034, 2004

5）Iwasa S, Nakajima TE, Nakamura K, et al：First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer. Gastric Cancer 15：21-26, 2012

6）Ishigami H, Kitajima J, Kaisaki A, et al：PhaseⅡ study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol 21：67-70, 2010

7）Fushida S, Kinoshita J, Kaji M, et al：PhaseⅠ/Ⅱ study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis. Cancer Chemother Pharmacol 71：1265-1272, 2013

8）Markman M：Intraperitoneal antineoplastic drug delivery：rationale and results. Lancet Oncol 4：277-283, 2003

9）Fushida S, Kinoshita J, Yagi Y, et al：Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis：a feasibility and pharmacokinetic study. Oncol Rep 19：1305-1310, 2008

10）Kuramoto M, Shimada S, Ikeshima S, et al：Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg 150：242-246, 2009

11）Yu W, Whang I, Chung HY, et al：Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer：results of a prospective randomized trial. World J Surg 25：985-990, 2001

12）Kamijo Y, Ito C, Nomura M, et al：Surfactants influence the distribution of taxanes in peritoneal dissemination tumor-bearing rats. Cancer Let 287：182-186, 2010

13）Plummer R, Wilson RH, Calvert H, et al：A phase I clinical study of cisplatin-incorporated polymeric micelles（NC-6004）in patients with solid tumours. Br J Cancer 104：593-598, 2011